Tyrosine and phenylalanine restriction induces G0/G1 cell cycle arrest in murine melanoma in vitro and in vivo

Nutrition and Cancer

Volumn 29, Issue 2, 1997, Pages 104-113

  Fu, Ya Min ^a   Yu, Zu Xi ^b   Ferrans, Victor J ^b   Meadows, Gary G ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

^b NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE; CYCLINE; PHENYLALANINE; TYROSINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CANCER INHIBITION; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; MELANOMA; MOUSE; NONHUMAN;

ANIMALIA; MURINAE;

EID: 0031456990     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635589709514610     Document Type: Article

References (34)

1. Meadows, GG, and Oeser, DE: "Response of B16 melanoma-bearing mice to varying dietary levels of phenylalanine and tyrosine." Nutr Rep Int 28, 1073-1082, 1983.
2. Pierson, HF, and Meadows, GG: "Sodium ascorbate enhancement of carbidopa-levodopa methyl ester antitumor activity against pigmented B16 melanoma." Cancer Res 43, 2047-2051, 1983.
3. Meadows, GG, Pierson, HF, Abdallah, RM, and Desai, PR: "Dietary influence of tyrosine and phenylalanine on the response of B16 melanoma to carbidopa-levodopa methyl ester chemotherapy." Cancer Res 42, 3056-3063, 1982.
4. Abdallah, RM, Starkey, JR, and Meadows, GG: "Dietary restriction of tyrosine and phenylalanine: inhibition of metastasis of three rodent tumors." JNCI 78, 759-766, 1987.
5. Elstad, CA, Meadows, GG, and Abdallah, RM: "Specificity of the suppression of metastatic phenotype by tyrosine and phenylalanine restriction." Clin Exp Metastasis 8, 393-416, 1990.
6. Elstad, CA, and Meadows, GG: "Modulation of B16-BL6 murine melanoma metastatic phenotype by tyrosine and phenylalanine restriction in the absence of host selection pressures." Anticancer Res 13, 523-528, 1993.
7. Ershler, WB, Berman, E, and Moore, AL: "Slower B16 melanoma growth but greater pulmonary colonization in calorie-restricted mice." JNCI 76, 81-85, 1986.
8. Elstad, CA, and Meadows, GG: "Phenotypic stability of B16-BL6 melanoma exposed to low levels of tyrosine and phenylalanine." Anticancer Res 10, 1313-1318, 1990.
9. Green, A, Bain, C, McLennan, R, and Siskind, V: "Risk factors for cutaneous melanoma in Queensland." In Recent Results in Cancer Research. Epidemiology of Malignant Melanoma, RP Gallagher (ed). Berlin: Springer-Verlag, 1986, vol 102, pp 76-97.
10. Poste, G, Doll, J, Hart, IR, and Fidler, IJ: "In vitro selection of murine B16 melanoma variants with enhanced tissue-invasive properties." Cancer Res 40, 1636-1644, 1980.
11. Yu, Z-X, Biro, S, Fu, Y-M, Sanchez, J, Smale, G, et al.: "Localization of basic fibroblast growth factor in bovine endothelial cells: immunohistochemical and biochemical studies." Exp Cell Res 204, 247-259, 1993.
12. Hart, IR: "The selection and characterization of an invasive variant of the B16 melanoma." Am J Pathol 97, 587-600, 1979.
13. Ewen, ME, Sluss, HK, Whitehouse, LL, and Livingston, DM: "TGFβ inhibition of Cdk4 synthesis is linked to cell cycle arrest." Cell 74, 1009-1020, 1993.
14. Schutte, B, Reynders, MMJ, Bosman, FT, and Blijham, GH: "Flow cytometric determination of DNA ploidy level in nuclei isolated from paraffin-embedded tissue." Cytometry 6, 26-30, 1985.
15. Von Roenn, JH, Kheir, SM, Wolter, JM, and Coon, JS: "Significance of DNA abnormalities in primary malignant melanoma and nevi, a retrospective flow cytometric study." Cancer Res 46, 3192-3195, 1986.
16. Biro, S, Fu, Y-M, Yu, Z-X, and Epstein, SE: "Inhibitory effects of antisense oligodeoxynucleotides targeting c-myc mRNA on smooth muscle proliferation and migration." Proc Natl Acad Sci USA 90, 654-658, 1993.
17. Speir, E, and Epstein, SE: "Inhibition of smooth muscle cell proliferation by an antisense oligodeoxynucleotide targeting the messenger RNA encoding proliferating cell nuclear antigen." Circulation 86, 538-547, 1992.
18. Zhang, W, Grasso, L, McClain, CD, Gambel, AM, Cha, Y, et al.: "p53-Independent induction of WAFA1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation." Cancer Res 55, 668-674, 1995.
19. Waseem, NH, and Lane, DP: "Monoclonal antibody analysis of the proliferating cell nuclear antigen (PCNA)." J Cell Sci 96, 121-129, 1990.
20. Bravo, R, Frank, R, Blundell, PA, and MacDonald-Bravo, H: "Cyclin/PCNA is the auxiliary protein of DNA polymerase δ." Nature 326, 515-517, 1987.
21. Sherr, CJ: "G1 phase progression: cycling on cue." Cell 79, 551-555, 1994.
22. Toyoshima, H, and Hunter, T: "p27, a novel inhibitor of G1 cyclin-CDK protein kinase activity, is related to p21." Cell 78, 67-74, 1994.
23. Hirama, T, and Koeffler, HP: "Role of the cyclin-dependent kinase inhibitors in the development of cancer." Blood 86, 841-854, 1995.
24. Iida, A, Hirose, K, Arai, M, Yamaguchi, A, and Naksgawara, G: "Relationships among the expression of epidermal growth factor receptor, proliferating cell nuclear antigen labeling index, and lymph node metastasis in gastric cancer." Oncology 52, 189-195, 1995.
25. Tanaka, S, Haruma, K, Tatsuta, S, Hiraga, Y, Teixeira, CR, et al.: "Proliferating cell nuclear antigen expression correlates with the metastatic potential of submucosal invasive colorectal carcinoma." Oncology 52, 134-139, 1995.
26. Hunter, T, and Pines, J: "Cyclins and cancer. II. Cyclin D and CDK inhibitors come of age." Cell 79, 573-582, 1994.
27. cdc2 activation required for apoptosis." Science 73, 1059-1065, 1993.
28. Matthias, P, and Herskowitz, I: "Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle." Cell 79, 181-184, 1994.
29. Kip1: chromosomal mapping to 12p12-13.1 and absence of mutations in human tumors." Cancer Res 55, 1211-1214, 1995.
30. Singh, RK, and Siegal, GP: "Amino acid transport systems modulate human tumor cell growth and invasion: a working hypothesis." Med Hypotheses 44, 195-201, 1995.
31. Mcmillan, TJ, Rao, J, and Hart, IR: "Enhancement of experimental metastasis by pretreatment of tumour cells with hydroxyurea." Int J Cancer 38, 61-65, 1986.
32. Iwaski, T, Shinkai, K, Mukai, M, Yoshioka, K, Fujii, Y, et al.: "Cell-cycle-dependent invasion in vitro by rat ascites hepatoma cells." Int J Cancer 63, 282-287, 1995.
33. Bates, S, Bonnetta, L, MacAllan, D, Parry, D, Holder, A, et al.: "CDK6 (PLSTIRE) and CDK (PSK-J3) are a distinct subset of the cyclin-dependent kinases that associate with cyclin D1." Oncogene 9, 71-79, 1994.
34. Weinstat-Saslow, D, Merino, MJ, Manrow, RE, Lawrence, JA, Bluth, RF, et al.: "Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions." Nature Med 1, 1257-1260, 1994.